ALK Testing and Targeted Treatment Considerations in NSCLC

 

WCLC 2022 Conference Coverage
Z

WCLC 2022 on the Progression Pattern, Resistance Mechanism, and Subsequent Therapy for ALK+ NSCLC in the Era of 2nd Gen ALK-TKIs

By WCLC 2022 Conference Coverage FEATURING Zihua Zou
By WCLC 2022 Conference Coverage FEATURING Zihua Zou
173 views
August 23, 2022
0 Comments
Login to view comments. Click here to Login
ALK Testing and Targeted Treatment Considerations in NSCLC
05:52
WCLC 2022 Conference Coverage

WCLC 2022 on the Progression Pattern, Resistance Mechanism, and Subs…

Feat. Z. Zou
15:38
Malinda Itchins

Outcomes From ALEX and ALESIA Trials on Alectinib in ALK+ NSCLC

09:59
Association of Community Cancer Centers (ACCC)

Review of Immunohistochemistry for Advanced NSCLC Biomarker Testing

Feat. T. Allen
16:35
GRACE

Liquid Biopsies in NSCLC: Current Applications

Feat. J. Thompson
21:10
GRACE

Tissue Genotyping: Challenges and Best Practices - Optimal NGS Platf…

Feat. J. Weiss
25:03
Shirish Gadgeel

What Is the Optimal 1L ALK Therapy in 2022?